ARCHIVES

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

This article is from The Cancer Letter archive.

Vol. 15 No. 32 | August 11, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

NCI Starts $2 Million Study On Cancer Patient Job Discrimination

January 17, 1975

House Committee on Appropriations approves $28.5 billion for NIH.

June 24, 2005

In Brief: Most NCI Grants, Including Noncompeting And r01s, Will Take Cuts Of At Least 4 Percent; Paylines Set

January 22, 1982

12 Minority CCOPs Awardees Names, San Antonio Gets 2

September 21, 1990

Doubling Of Cancer Research Budget To Take Eight Years Under Obama Plan

May 15, 2009